Related Experiment Video
Updated: Aug 13, 2025

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi
Giulio Rizzetto1, Daisy Gambini1, Andrea Maurizi1
1Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.
Abstract:
Antibiotic resistance is rapidly increasing, and new anti-infective therapies are urgently needed. In this regard, antimicrobial peptides (AMPs) may represent potential candidates for the treatment of infections caused by multiresistant microorganisms. In this narrative review, we reported the experience of our research group over 20 years. We described the AMPs we evaluated against Gram-positive, Gram-negative, and fungi. In conclusion, our experience shows that AMPs can be a key option for treating multiresistant infections and overcoming resistance mechanisms. The combination of AMPs allows antibiotics and antifungals that are no longer effective to exploit the synergistic effect by restoring their efficacy. A current limitation includes poor data on human patients, the cost of some AMPs, and their safety, which is why studies on humans are needed as soon as possible.
Insights
Antimicrobial peptides (AMPs) show promise in treating infections from drug-resistant microbes. Combining AMPs can restore the efficacy of older antibiotics and antifungals, though human studies are needed.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Rising antibiotic resistance necessitates novel anti-infective strategies.
- Multidrug-resistant (MDR) infections pose a significant global health threat.
- Antimicrobial peptides (AMPs) are emerging as potential therapeutic agents.
Purpose of the Study:
- To review 20 years of research on AMPs evaluated by the group.
- To assess the efficacy of AMPs against Gram-positive, Gram-negative bacteria, and fungi.
- To explore the potential of AMPs in combating antimicrobial resistance.
Main Methods:
- Narrative review of 20 years of the research group's experience.
- Evaluation of various AMPs against a spectrum of microbial pathogens.
- Analysis of AMPs' effectiveness in overcoming resistance mechanisms.
Main Results:
- AMPs demonstrated efficacy against Gram-positive, Gram-negative bacteria, and fungi.
- Combinations of AMPs with existing antibiotics/antifungals restored their lost efficacy.
- Synergistic effects were observed when AMPs were combined with conventional antimicrobials.
Conclusions:
- AMPs represent a promising therapeutic option for treating multidrug-resistant infections.
- AMP combination therapy can overcome established antimicrobial resistance mechanisms.
- Further clinical studies are essential to address safety, cost, and efficacy in human patients.
More Related Videos
Related Concept Videos
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Biological Methods for Microbial Control
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Gene Regulation in Microbial Communities: Quorum Sensing
Combined Effects of Drugs: Synergism
Such synergistic combinations...

